Delivery Order SPE2DE24D0013-SPE2D625F64KY
- Not listed
- This is a federal contract award to Cepheid, a manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $8,976.00, is for the delivery of SARS-COV-2 FLU RSV 10S test kits. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 29, 2025. The contract has no set-aside designation. Cepheid is the prime contractor and has a history of providing molecular diagnostic equipment, reagents, and test kits to...
- This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the provision of SARS-COV-2 FLU RSV 10S diagnostic test kits, with a ceiling value of $17,952.00 and a performance period ending on May 28, 2025. This contract is not set aside for any specific business category. Cepheid is an...
- This is a $5,701.50 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of SARS-CoV-2 test kits, reagents, and associated supplies to support the Department of Defense's COVID-19 testing efforts. The award has an ultimate completion date of May 28, 2024. Cepheid is the prime contractor and original equipment manufacturer, and there is no set-aside designation for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $11,220.00, is a firm fixed-price delivery order for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic test kits. The contract has no set-aside designation. Cepheid is the prime contractor and has provided molecular diagnostic testing equipment, reagents, test kits, and maintenance services to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $19,773.60, is for the provision of XPRSARS-COV2-10 test kits, which are used to detect the SARS-CoV-2 virus that causes COVID-19. The contract has a firm fixed price and is not designated as a set-aside. Cepheid is the prime contractor, and the contract has an ultimate completion date of August 19, 2024....
- This is a delivery order contract awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency Troop Support Medical. The $6,732 firm fixed price contract is for the supply of SARS-COV-2, flu, and RSV test kits. The contract has a period of performance through September 25, 2024. Cepheid has been awarded numerous prime federal contracts and indefinite delivery vehicles with agencies like the Department of Veterans Affairs to provide...
- This is a $8,160.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The award is for the provision of XPCOV2/FLU/RSV-10 test kits, which are used to detect COVID-19, influenza, and respiratory syncytial virus. This award does not have a set-aside designation. Cepheid has received numerous other federal prime contracts and subcontracts from agencies such as the Department of Veterans Affairs and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $1,270.50 contract is for the delivery of SARS-CoV-2 test kits. The contract has an ultimate completion date of March 28, 2024. Cepheid is the prime contractor and original equipment manufacturer. This award is not associated with a set-aside designation. Cepheid has received numerous prime federal contracts and subcontracts from...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for SARS-CoV-2, flu, and respiratory syncytial virus (RSV) test kits. The contract has a ceiling value of $28,512.00 and is a firm fixed-price delivery order with a period of performance ending on March 19, 2025. Cepheid is the prime contractor and there is no set-aside designation. The contract is part of a larger Indefinite Delivery Vehicle (IDV)...
- This federal contract award, valued at $15,708, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the delivery of SARS-CoV-2, flu, and respiratory syncytial virus (RSV) test kits, with a period of performance through August 2024. This is a fixed-price contract with economic price adjustment, and does not have a set-aside designation. Cepheid has received numerous prime...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F64KYDelivery Order
This is a $8,976.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the supply of SARS-COV-2 FLU RSV 10S test kits and is not set aside. Cepheid is the prime contractor and has previously been awarded other federal contracts and grants, including an Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for COVID-19 and respiratory virus testing supplies, and a Blanket Purchase Agreement with the Indian Health Service for testing kits. The company specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. This contract supports the DLA's efforts to provide comprehensive molecular diagnostic testing capabilities to the U.S. military and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 2/6/25 |